Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

990395

registered interest
date	18/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the NHS Long-Term Plan will ensure that every patient with secondary breast cancer has access to a tailored health and wellbeing event that includes psychological support and opportunities to meet other people with secondary breast cancer.
tabling member constituency	North Warwickshire
tabling member printed	Craig Tracey
uin	181332
answer	answer is ministerial correction date of answer 24/10/2018 answer text <p>We are committed to rolling out the recovery package to every cancer patient by 2020. The recovery package is a set of four interventions designed to help patients and clinicians assess a patient’s holistic needs and plan appropriately for their care and support, and includes a health and wellbeing event – or similar – empowering patients to independently manage their own health, with advice and support.</p><p> </p><p>The National Health Service Long Term Plan provides an excellent opportunity to look at how cancer and other services can be further improved over the next decade. The plan is currently in development and will be published later in the year.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/10/2018 12:42:03 answering member 4067 label Biography information for Steve Brine
tabling member	4509 label Biography information for Craig Tracey

990404

registered interest
date	18/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what (a) financial support and (b) other resources his Department has provided to Cancer Alliances for long-term planning for breast cancer care.
tabling member constituency	Newcastle upon Tyne North
tabling member printed	Catherine McKinnell
uin	181271
answer	answer is ministerial correction date of answer 23/10/2018 answer text <p>NHS England provides funding, support and guidance to Cancer Alliances to ensure the delivery of improvements in early and faster diagnosis and quality of life for people living with and beyond cancer, including breast cancer patients.</p><p>For this year, all Cancer Alliances have agreed plans in place for using transformation funding, focused on the delivery of NHS England’s 2018/19 Planning Guidance priorities. As part of these plans, Alliances will:</p><p>- progress towards the 2020/21 ambition for all breast cancer patients to move to a stratified follow-up pathway after treatment; and</p><p>- have in place clinically agreed protocols for stratifying breast cancer patients and a system for remote monitoring by the end of 2018/19.</p><p>In addition to transformation funding, support that all Cancer Alliances will receive in 2018/19 to transform care for their cancer patients includes:</p><p>- dedicated support from the National Cancer Programme’s analysis, evidence and data service;</p><p>- support and assurance from NHS England regional offices;</p><p>- a tailored programme of leadership development; and</p><p>- a series of national events to share best practice and information across Cancer Alliances.</p><p>More information about the levels of transformation funding received by each Cancer Alliance in 2018/19, and how they are using this to improve cancer care, can be found on NHS England’s website at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/cancer/improve/cancer-alliances-improving-care-locally/nhs-england-support-and-funding-for-cancer-alliances/" target="_blank">https://www.england.nhs.uk/cancer/improve/cancer-alliances-improving-care-locally/nhs-england-support-and-funding-for-cancer-alliances/</a></p><p> </p><p> </p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/10/2018 16:45:11 answering member 4067 label Biography information for Steve Brine
tabling member	4125 label Biography information for Catherine McKinnell

983134

registered interest
date	08/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with Health Education England on training more breast radiologists and mammographers.
tabling member constituency	Sunderland Central
tabling member printed	Julie Elliott
uin	176300
answer	answer is ministerial correction date of answer 11/10/2018 answer text <p>Health Education England (HEE) published its first ever Cancer Workforce Plan in December 2017, which commits to the expansion of capacity and skills including an ambition to increase improved working practices, attracting qualified people back to the National Health Service through domestic and international recruitment. This will include 668 more, full time equivalent, clinical radiologists and investing in 300 reporting radiographers by 2021 to support an increase in the capacity for earlier diagnosis.</p><p> </p><p>HEE intends to follow the plan later this year with a longer-term strategy that looks at the workforce needs beyond 2021. This will include exploring sustainable growth beyond 2021 in key professions through continued investment in training places, with a greater focus on attracting and retaining students and improving the numbers of qualified professionals who go on to work in the NHS.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/10/2018 16:42:09 answering member 4067 label Biography information for Steve Brine
tabling member	4127 label Biography information for Julie Elliott

967836

registered interest
date	04/09/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the rate of (a) age-standardised premature mortality from breast cancer and (b) uptake of screening for that cancer was in each clinical commissioning group area in the last period for which figures are available.
tabling member constituency	Lincoln
tabling member printed	Karen Lee
uin	170447
answer	answer is ministerial correction date of answer 12/09/2018 answer text <p>The Office for National Statistics has published data on the number of deaths and age-standardised mortality rates where breast cancer (ICD-10 code: C50) was the underlying cause of death, in those aged 0 to 74 years, by sex, England and Wales, 2012 to 2016 at the following link:</p><p> </p><p><a href="https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/causesofdeath/adhocs/008966deathsandagestandardisedmortalityrateswherebreastcancerwastheunderlyingcauseaged0to74yearsbysexenglandandwales2012to2016" target="_blank">https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/causesofdeath/adhocs/008966deathsandagestandardisedmortalityrateswherebreastcancerwastheunderlyingcauseaged0to74yearsbysexenglandandwales2012to2016</a></p><p> </p><p>Data on the uptake of breast cancer screening are not available by clinical commissioning group level. Figures for uptake for screening during 2016/17 (screening year of 1 April 2016 to 31 March 2017) are published by NHS Digital. The information for each area is provided at a breast screening service level is attached.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/09/2018 16:29:52 answering member 4067 label Biography information for Steve Brine attachment 1 file name PQ170447 document format.xlsx title PQ170447 attached document
tabling member	4664 label Biography information for Karen Lee

947427

registered interest
date	24/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the levels of care and support available for women with breast cancer in (a) the West Midlands and (b) England.
tabling member constituency	Birmingham, Northfield
tabling member printed	Richard Burden
uin	167862
answer	answer is ministerial correction date of answer 10/09/2018 answer text <p>Birmingham and Solihull Clinical Commissioning Group, advises that breast cancer patients in Birmingham have support from a clinical nurse specialist and have a health needs assessment, which can refer patients for services including prosthesis fitting, wig referral, psychology service and lymphoedema service. In addition, there are several third sector organisations that provide a range of support to breast cancer patients across the area.</p><p> </p><p>NHS England is committed to transforming cancer care across England for all cancers, including breast cancer, aiming to reduce inequality and promoting equity of access to services. To support this ambition, NHS England has committed more than £200 million in 2017/18 and 2018/19 to fund Cancer Alliances to accelerate early diagnosis of cancer, improve survival and enhance quality of life.</p><p> </p><p>In February 2018, in partnership with the Department and NHS England, Public Health England (PHE) launched a Be Clear on Cancer Campaign focused on breast cancer in women aged over 70 to raise awareness of specific symptoms and encourage those with symptoms to visit their doctor.</p><p> </p><p>To improve the uptake of screening, NHS England is continuing to invest in initiatives to help ensure equality of access, including through locally targeted interventions. These include text and general practitioner reminders and PHE’s new ‘Breast screening: easy guide’, which helps women decide whether screening is right for them.</p><p> </p><p>NHS England agreed a Commercial Access Agreement with Roche for Kadcyla (trastuzumab emtansine) which brought the confidential purchase price below the National Institute for Health and Care Excellence cost-effectiveness threshold, allowing approval in routine commissioning. This is offering breast cancer patients precious quality time with their families without damaging side effects.</p><p> </p><p>Finally, we are committed to rolling out stratified follow-up pathways for breast cancer patients by 2020, to ensure patients get the right care after treatment, including information and support to spot signs and symptoms of recurrence or secondary cancer. As well as providing a better experience for patients and ensuring they have the information they need, stratified pathways can offer more effective use of resources by freeing up outpatient capacity. They can also ensure that in cases where there is recurrence or secondary cancer, patients are supported to return to care quickly and effectively.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/09/2018 16:58:31 answering member 4067 label Biography information for Steve Brine
tabling member	301 label Biography information for Richard Burden

946904

registered interest
date	23/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on the implementation of the Cancer Strategy in relation to breast cancer.
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
uin	167281
answer	answer is ministerial correction date of answer 04/09/2018 answer text <p>NHS England is committed to transforming cancer care across England for all cancers, including breast cancer, aiming to reduce inequality and promoting equity of access to services. To support this ambition, NHS England has committed more than £200 million in 2017/18 and 2018/19 to fund Cancer Alliances to accelerate early diagnosis of cancer, improve survival and enhance quality of life.</p><p> </p><p>In February 2018, in partnership with the Department and NHS England, Public Health England (PHE) launched a Be Clear on Cancer Campaign focused on Breast Cancer in women aged over 70 to raise awareness of specific symptoms and encourage those with symptoms to visit their doctor.</p><p> </p><p>To improve the uptake of screening, NHS England is continuing to invest in initiatives to help ensure equality of access, including through locally targeted interventions. These include text and general practitioner reminders and PHE’s new ‘Breast screening: easy guide’, which helps women decide whether screening is right for them.</p><p> </p><p>NHS England agreed a Commercial Access Agreement with Roche for Kadcyla (trastuzumab emtansine) which brought the confidential purchase price below the National Institute for Health and Care Excellence cost-effectiveness threshold, allowing approval in routine commissioning. This is offering breast cancer patients precious quality time with their families without damaging side effects.</p><p> </p><p>Finally, we are committed to rolling out stratified follow-up pathways for breast cancer patients by 2020, to ensure patients get the right care after treatment, including information and support to spot signs and symptoms of recurrence or secondary cancer. As well as providing a better experience for patients and ensuring they have the information they need, stratified pathways can offer more effective use of resources by freeing up outpatient capacity. They can also ensure that in cases where there is recurrence or secondary cancer, patients are supported to return to care quickly and effectively.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 04/09/2018 16:03:08 answering member 4067 label Biography information for Steve Brine
tabling member	4243 label Biography information for Dan Jarvis

933856

registered interest
date	02/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when the DNA test for breast cancer assessment will be available on the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	159604
answer	answer is ministerial correction date of answer 09/07/2018 answer text <p>Some forms of DNA testing for cancer are available on the National Health Service. For example, the BRCA1 and BRCA2 genes raise the risk of cancer if they become altered. Having a variant BRCA gene greatly increases a woman's chance of developing breast cancer and ovarian cancer. The National Institute for Health and Care Excellence guidelines require that people with a 10% or higher risk of carrying BRCA genes are able to be counselled, supported and tested.</p><p> </p><p>However, many other DNA tests for breast cancer are still in the research phase, and are therefore not routinely available.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/07/2018 15:39:50 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon